SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:1SXP - DE000A3ENQ51 - Common Stock
1SXP.DE Key Statistics, Chart & Performance
The current stock price of 1SXP.DE is 15.39 EUR. In the past month the price decreased by -9.68%. In the past year, price decreased by -39.65%.
1SXP.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 51.25 | 21.50B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 49.72 | 20.86B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 56.43 | 19.27B | ||
| SRT.DE | SARTORIUS AG | 43.51 | 14.86B | ||
| QIA.DE | QIAGEN N.V. | 20.31 | 8.94B | ||
| EVT.DE | EVOTEC SE | N/A | 2.24B | ||
| GXI.DE | GERRESHEIMER AG | 7.47 | 952.61M | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.38 | 203.83M | ||
| ALECR.PA | EUROFINS CEREP-REGR | 24.9 | 178.00M | ||
| MLC.I | MALIN CORP PLC | N/A | 34.64M |
Related stock screener links
About 1SXP.DE
Company Profile
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
Company Info
SCHOTT PHARMA AG& CO KGAA
Hattenbergstrasse 10
MAINZ HESSEN DE
Employees: 4811
Phone: 496131660
SCHOTT PHARMA AG& CO KGAA / 1SXP.DE FAQ
Can you describe the business of SCHOTT PHARMA AG& CO KGAA?
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
What is the current price of 1SXP stock?
The current stock price of 1SXP.DE is 15.39 EUR. The price increased by 0.59% in the last trading session.
Does SCHOTT PHARMA AG& CO KGAA pay dividends?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a dividend yield of 1.19%. The yearly dividend amount is currently 0.16.
What is the ChartMill rating of SCHOTT PHARMA AG& CO KGAA stock?
1SXP.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Would investing in SCHOTT PHARMA AG& CO KGAA be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1SXP.DE.
What is the employee count for 1SXP stock?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) currently has 4811 employees.
1SXP.DE Technical Analysis
1SXP.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1SXP.DE. 1SXP.DE scores excellent on profitability, but there are some minor concerns on its financial health.
1SXP.DE Financial Highlights
Over the last trailing twelve months 1SXP.DE reported a non-GAAP Earnings per Share(EPS) of 0.97. The EPS decreased by -2.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.85% | ||
| ROA | 9.16% | ||
| ROE | 16.42% | ||
| Debt/Equity | 0.09 |
1SXP.DE Forecast & Estimates
19 analysts have analysed 1SXP.DE and the average price target is 23.9 EUR. This implies a price increase of 55.28% is expected in the next year compared to the current price of 15.39.
For the next year, analysts expect an EPS growth of 5.75% and a revenue growth 4.39% for 1SXP.DE